{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:49:57Z","timestamp":1791125397422,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.semcancer.2012.06.002","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T11:03:50Z","timestamp":1339585430000},"page":"46-55","source":"Crossref","is-referenced-by-count":134,"title":["The metabolic basis of kidney cancer"],"prefix":"10.1016","volume":"23","author":[{"given":"W. Marston","family":"Linehan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Ricketts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2012.06.002_bib0005","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1097\/01.ju.0000096060.92397.ed","article-title":"The genetic basis of cancer of the kidney","volume":"170","author":"Linehan","year":"2003","journal-title":"Journal of Urology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrurol.2010.47","article-title":"The genetic basis of kidney cancer: a metabolic disease","volume":"7","author":"Linehan","year":"2010","journal-title":"Nature Reviews Urology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0015","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel\u2013Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archopht.125.2.239","article-title":"Genotype-phenotype correlation in von Hippel\u2013Lindau disease with retinal angiomatosis","volume":"125","author":"Wong","year":"2007","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/WNL.41.1.41","article-title":"Central nervous system involvement in von Hippel\u2013Lindau disease","volume":"41","author":"Filling-Katz","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0030","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3171\/jns.2004.100.3.0480","article-title":"Endolymphatic sac tumors in von Hippel\u2013Lindau disease","volume":"100","author":"Choo","year":"2004","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0035","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0090-4295(97)00074-5","article-title":"Epididymal cystadenomas in von Hippel\u2013Lindau disease","volume":"49","author":"Choyke","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0040","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1067\/msy.1998.91823","article-title":"Pancreatic neuroendocrine tumors associated with von Hippel\u2013Lindau disease: diagnostic and management recommendations","volume":"124","author":"Libutti","year":"1998","journal-title":"Surgery"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0045","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.surg.2007.09.012","article-title":"Clinical, genetic and radiographic analysis of 108 patients with von Hippel\u2013Lindau disease (VHL) manifested by pancreatic neuroendocrine tumors (PNETs)","volume":"142","author":"Blansfield","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00005392-199501000-00009","article-title":"Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel\u2013Lindau disease: clinical and molecular genetic implications","volume":"153","author":"Poston","year":"1995","journal-title":"Journal of Urology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0055","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0022-5347(01)66674-6","article-title":"Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel\u2013Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications","volume":"154","author":"Walther","year":"1995","journal-title":"Journal of Urology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0060","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0022-5347(05)68930-6","article-title":"Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery","volume":"161","author":"Walther","year":"1999","journal-title":"Journal of Urology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0065","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0022-5347(05)66524-X","article-title":"Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience","volume":"165","author":"Herring","year":"2001","journal-title":"Journal of Urology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.ju.0000132127.79974.3f","article-title":"The relationship between renal tumor size and metastases in patients with von Hippel\u2013Lindau disease","volume":"172","author":"Duffey","year":"2004","journal-title":"Journal of Urology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0075","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/0888-7543(90)90249-T","article-title":"Localization of the von Hippel\u2013Lindau disease gene to a small region of chromosome 3","volume":"8","author":"Hosoe","year":"1990","journal-title":"Genomics"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0080","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel\u2013Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K","article-title":"Improved detection of germline mutations in the von Hippel\u2013Lindau disease tumor suppressor gene","volume":"12","author":"Stolle","year":"1998","journal-title":"Human Mutation"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0090","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1158\/1078-0432.CCR-07-4921","article-title":"Improved identification of von Hippel\u2013Lindau gene alterations in clear cell renal tumors","volume":"14","author":"Nickerson","year":"2008","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pgen.1002312","article-title":"Von Hippel\u2013Lindau (VHL) inactivation in sporadic clear cell renal cancer: Associations with germline VHL polymorphisms and etiologic risk factors","volume":"7","author":"Moore","year":"2011","journal-title":"PLoS Genetics"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0100","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1126\/science.7660122","article-title":"Inhibition of transcription elongation by the VHL tumor suppressor protein","volume":"269","author":"Duan","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0105","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1073\/pnas.94.6.2156","article-title":"The von Hippel\u2013Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins","volume":"94","author":"Pause","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0110","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.7660130","article-title":"Binding of the von Hippel\u2013Lindau tumor suppressor protein to elongin B and C","volume":"269","author":"Kibel","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0115","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1126\/science.284.5414.657","article-title":"Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase","volume":"284","author":"Kamura","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0120","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/35017054","article-title":"Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel\u2013Lindau protein","volume":"2","author":"Ohh","year":"2000","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0130","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel\u2013Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0135","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa021491","article-title":"A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer","volume":"349","author":"Yang","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa060655","article-title":"Sorafenib in advanced clear-cell renal-cell carcinoma","volume":"356","author":"Escudier","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0150","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa066838","article-title":"Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma","volume":"356","author":"Hudes","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0155","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(08)61039-9","article-title":"Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial","volume":"372","author":"Motzer","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0160","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1200\/JCO.2009.23.9764","article-title":"Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial","volume":"28","author":"Sternberg","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0165","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-5347(17)35015-2","article-title":"Hereditary papillary renal cell carcinoma","volume":"151","author":"Zbar","year":"1994","journal-title":"Journal of Urology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0170","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9440(10)65147-4","article-title":"Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype","volume":"155","author":"Lubensky","year":"1999","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0175","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0022-5347(05)67893-7","article-title":"Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer","volume":"163","author":"Ornstein","year":"2000","journal-title":"Journal of Urology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0180","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nature Genetics"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0185","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/01.ju.0000139583.63354.e0","article-title":"Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the Met proto-oncogene","volume":"172","author":"Schmidt","year":"2004","journal-title":"Journal of Urology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0190","doi-asserted-by":"crossref","first-page":"e4771","DOI":"10.1371\/journal.pone.0004771","article-title":"Uncoupling of the LKB1-AMPKalpha energy sensor pathway by growth factors and oncogenic BRAF","volume":"4","author":"Esteve-Puig","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0195","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1101\/gad.1756509","article-title":"Tumor suppressors and cell metabolism: a recipe for cancer growth","volume":"23","author":"Jones","year":"2009","journal-title":"Genes and Development"},{"issue":"May (Suppl.)","key":"10.1016\/j.semcancer.2012.06.002_bib0200","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1200\/jco.2008.26.15_suppl.5103","article-title":"A phase II study of the dual MET\/VEGFR2 inhibitor XL880 in patients (pts) with papillary renal carcinoma (PRC)","volume":"26","author":"Srinivasan","year":"2008","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0205","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1001\/archderm.1977.01640120042005","article-title":"Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons","volume":"113","author":"Birt","year":"1977","journal-title":"Archives of Dermatology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0210","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1164\/rccm.200610-1483OC","article-title":"Lung cysts, spontaneous pneumothrorax and genetic associations in 89 families with Birt\u2013Hogg\u2013Dub\u00e9 syndrome","volume":"175","author":"Toro","year":"2007","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0215","first-page":"393","article-title":"Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt\u2013Hogg\u2013Dub\u00e9 syndrome","volume":"11","author":"Zbar","year":"2002","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0220","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","article-title":"Renal tumors in the Birt\u2013Hogg\u2013Dub\u00e9 syndrome","volume":"26","author":"Pavlovich","year":"2002","journal-title":"American Journal of Surgical Pathology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0225","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1535-6108(02)00104-6","article-title":"Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt\u2013Hogg\u2013Dub\u00e9 syndrome","volume":"2","author":"Nickerson","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0230","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/jmg.2007.054304","article-title":"BHD mutations, clinical and molecular genetic investigations of Birt\u2013Hogg\u2013Dub\u00e9 syndrome: a new series of 50 families and a review of published reports","volume":"45","author":"Toro","year":"2008","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0235","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jnci\/dji154","article-title":"High frequency of somatic frameshift BHD gene mutations in Birt\u2013Hogg\u2013Dub\u00e9-associated renal tumors","volume":"97","author":"Vocke","year":"2005","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0240","doi-asserted-by":"crossref","first-page":"15552","DOI":"10.1073\/pnas.0603781103","article-title":"Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling","volume":"103","author":"Baba","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0245","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.gene.2008.02.022","article-title":"Identification and characterization of a novel folliculin-interacting protein FNIP2","volume":"415","author":"Hasumi","year":"2008","journal-title":"Gene"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0250","doi-asserted-by":"crossref","first-page":"18722","DOI":"10.1073\/pnas.0908853106","article-title":"Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2","volume":"106","author":"Hasumi","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0255","doi-asserted-by":"crossref","first-page":"e15793","DOI":"10.1371\/journal.pone.0015793","article-title":"Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization","volume":"5","author":"Hong","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0260","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/jnci\/djm288","article-title":"Kidney-targeted Birt\u2013Hogg\u2013Dub\u00e9 gene inactivation in a mouse model: Erk1\/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys","volume":"100","author":"Baba","year":"2008","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0265","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.juro.2010.08.092","article-title":"Transcription factor E3 and transcription factor EB renal cell carcinomas: clinical features, biological behavior and prognostic factors","volume":"185","author":"Malouf","year":"2011","journal-title":"Journal of Urology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0270","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000134127","article-title":"Mapping the X chromosome breakpoint in two papillary renal cell carcinoma cell lines with a t(X;1)(p11.2;q21.2) and the first report of a female case","volume":"71","author":"Shipley","year":"1995","journal-title":"Cytogenetics and Cell Genetics"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0275","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/hmg\/5.9.1333","article-title":"The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 tanscription factor gene","volume":"5","author":"Sidhar","year":"1996","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0280","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000134444","article-title":"Molecular cloning of the papillary renal cell carcinoma-associated translocation (X;1)(p11;q21) breakpoint","volume":"75","author":"Weterman","year":"1996","journal-title":"Cytogenetics and Cell Genetics"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0285","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/sj.onc.1201394","article-title":"Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma","volume":"15","author":"Clark","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0290","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/PAS.0b013e3181e8ce5b","article-title":"Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers","volume":"34","author":"Argani","year":"2010","journal-title":"American Journal of Surgical Pathology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0295","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/PAS.0b013e3181dd577e","article-title":"Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma","volume":"34","author":"Zhong","year":"2010","journal-title":"American Journal of Surgical Pathology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0300","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/00000478-200212000-00003","article-title":"PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21)","volume":"26","author":"Argani","year":"2002","journal-title":"American Journal of Surgical Pathology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0305","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5858\/2008-0391-RSR.1","article-title":"Xp11.2 translocation renal cell carcinoma","volume":"134","author":"Armah","year":"2010","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0310","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/S0002-9440(10)64680-9","article-title":"A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation","volume":"158","author":"Argani","year":"2001","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0315","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1073\/pnas.0931430100","article-title":"Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation","volume":"100","author":"Davis","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0320","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1002\/cncr.25562","article-title":"Characteristics of the coexistence of melanoma and renal cell carcinoma","volume":"116","author":"Maubec","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0325","doi-asserted-by":"crossref","DOI":"10.1038\/nature10539","article-title":"A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma","author":"Bertolotto","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0330","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1755-148X.2009.00653.x","article-title":"Fifteen-year quest for microphthalmia-associated transcription factor target genes","volume":"23","author":"Cheli","year":"2010","journal-title":"Pigment Cell and Melanoma Research"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0335","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/annonc\/mdq029","article-title":"Targeted agents in metastatic Xp11 translocation\/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network","volume":"21","author":"Malouf","year":"2010","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0340","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0345","first-page":"1","article-title":"Tuberous sclerosis-associated renal cell carcinoma clinical, pathological, and genetic features","volume":"149","author":"Bjornsson","year":"1996","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0350","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1535-6108(03)00187-9","article-title":"TSC2 regulates VEGF through mTOR-dependent and -independent pathways","volume":"4","author":"Brugarolas","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0355","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ccr.2004.06.020","article-title":"Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes","volume":"6","author":"Brugarolas","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0360","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0365","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/j.seminoncol.2007.07.009","article-title":"Cowden syndrome","volume":"34","author":"Gustafson","year":"2007","journal-title":"Seminars in Oncology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0370","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/ejhg.2008.162","article-title":"PTEN hamartoma tumor syndromes","volume":"16","author":"Blumenthal","year":"2008","journal-title":"European Journal of Human Genetics"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0375","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/humu.10257","article-title":"PTEN: one gene, many syndromes","volume":"22","author":"Eng","year":"2003","journal-title":"Human Mutation"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0380","doi-asserted-by":"crossref","first-page":"7066","DOI":"10.1158\/0008-5472.CAN-08-0922","article-title":"Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin","volume":"68","author":"Squarize","year":"2008","journal-title":"Cancer Research"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0385","first-page":"309","article-title":"Metabolism of the carcinoma cell","volume":"152","author":"Warburg","year":"1924","journal-title":"Biochemische Zeitschrift"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0390","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0395","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1073\/pnas.051633798","article-title":"Inherited susceptibility to uterine leiomyomas and renal cell cancer","volume":"98","author":"Launonen","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0400","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0022-5347(01)67601-8","article-title":"Hereditary papillary renal cell carcinoma: clinical studies in 10 families","volume":"153","author":"Zbar","year":"1995","journal-title":"Journal of Urology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0405","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/376435","article-title":"Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America","volume":"73","author":"Toro","year":"2003","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0410","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"American Journal of Surgical Pathology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0415","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.juro.2007.01.155","article-title":"Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer","volume":"177","author":"Grubb","year":"2007","journal-title":"Journal of Urology"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0420","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nature Genetics"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0425","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","article-title":"HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability","volume":"8","author":"Isaacs","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0430","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ccr.2011.07.018","article-title":"The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases metabolic propensities and lowers cellular iron levels","volume":"20","author":"Tong","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0435","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cancergencyto.2009.08.018","article-title":"UOK 262 cell line, fumarate hydratase deficient (FH-\/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer","volume":"196","author":"Yang","year":"2010","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0440","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma","volume":"287","author":"Baysal","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0445","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/81551","article-title":"Mutations in SDHC cause autosomal dominant paraganglioma, type 3","volume":"26","author":"Niemann","year":"2000","journal-title":"Nature Genetics"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0450","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc1013","article-title":"A role for mitochondrial enzymes in inherited neoplasia and beyond","volume":"3","author":"Eng","year":"2003","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0455","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.292.8.943","article-title":"Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations","volume":"292","author":"Neumann","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0460","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/381054","article-title":"Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma","volume":"74","author":"Vanharanta","year":"2004","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0465","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/djn254","article-title":"Germline SDHB mutations and familial renal cell carcinoma","volume":"100","author":"Ricketts","year":"2008","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.semcancer.2012.06.002_bib0470","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10689-009-9234-z","article-title":"SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis","volume":"8","author":"Henderson","year":"2009","journal-title":"Familial Cancer"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X12000946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X12000946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T21:20:31Z","timestamp":1642454431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X12000946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1044579X12000946"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2012.06.002","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}